DUBLIN--(BUSINESS WIRE)--The "Global Eubiotics Market: Focus on Offering Type (Probiotics, Prebiotics, Organic Acids), Applications (Gut Health, Immunity), Livestock Type (Swine, Poultry, Aquaculture) and End User - Analysis and Forecast, 2020-2025" report has been added to ResearchAndMarkets.com's offering.
The eubiotics market is projected to grow from $5.24 billion in 2019 to $7.74 billion by 2025, growing at a CAGR of 7.06% from 2020 to 2025.
The market report includes several drivers that are influencing the changing demand for and dynamics of the eubiotics industry. The eubiotics market has undergone significant and dynamic changes in the past five years, specifically with the introduction of new and advanced solutions to improve animal health and well-being.
With the increase in the world population leading to a rise in the global demand for meat food and the global prohibition on the usage of antibiotics growth promoters, livestock growers are increasingly adopting eubiotics products and ingredients to increase the yield and productivity of animals.
The utilization of eubiotics as an animal feed has resulted in promoting the growth and maintaining animal health by managing the gut health and reduction in the proliferation of the undesirable pathogenic bacteria. As a result, the eubiotics market is anticipated to progress due to the ever-growing affinity for more convenient animal feed solutions than the traditional methods.
High growth in the market is expected to be driven by the increasing consumption and demand for meat, growing livestock diseases, and ban on the utilization of antibiotics growth promoters. Governments of developed as well as developing countries have also taken several initiatives to promote eubiotics, especially after the ban on antibodies growth promoters. Moreover, the increasing demand for and consumption of the meat and meat-based products is also expected to drive the market in the future.
Competitive Landscape
The exponential utilization of advanced solutions in the eubiotics market has created opportunities for companies to adopt strategies such as collaborations, joint ventures, product launches, and developments and partnerships.
The established companies in the eubiotics market are focusing more on business expansions and on finding ways to improve the existing techniques. Moreover, product launch activities have increased in the market during the last three years. Presently, the big four eubiotics companies, namely Chr. Hansen Holding A/S, Koninklijke DSM N.V., Kemin Industries, Inc., and BASF, are constantly increasing their investment in animal health improvement, by acquiring or collaborating with other companies.
Several other companies, such as Anpario plc., Novus International Inc., Lallemand, Inc, and LESAFFRE, have launched different products to compete with the market-dominant players. The wide-spread adoption of advanced feed solutions is essential for linking the gap to improve animal health effectively.
Key Topics Covered:
1 Market Dynamics
1.1 Overview
1.2 Impact Analysis
1.3 Market Drivers
1.3.1 Increase in Consumption and Production of Meat and Meat-Based Products
1.3.2 Supplanting Antibiotic Growth Promoters (AGPs) With Eubiotics
1.3.3 Rapid Increases in the Livestock Disease
1.4 Market Restraints
1.4.1 Complexity in Trading due to Stringent Government Policies
1.4.2 Lack of Sufficient Scientific Evidence
1.5 Market Opportunities
1.5.1 Rapid Investment to Enhance Animal Nutrition
1.5.2 Opportunity to Invest on Consumer Awareness Amid COVID-19
2 Competitive Landscape
2.1 Key Strategies and Developments
2.2 Competitive Benchmarking of Key Eubiotics Companies
3 Industry Analysis
3.1 Supply Chain Analysis
3.2 Market Trends in the Eubiotics Market
3.2.1 Shift Towards Natural Functional Ingredients
3.2.2 Brand Differentiation Through Innovative Packaging
3.2.3 Outbreak of Corona Pandemic Arising Immunity Concerns in Consumers
3.2.4 Shift of Animal Husbandry Towards Efficient and Targeted Investments
3.3 Impact of COVID-19 on Eubiotics Market
3.3.1 Consumer Perception
3.3.2 Government Regulation and Impact on Supply Chain
3.3.3 The Way Forward for the Nutrition and Supplement Industry
3.4 Patent Analysis
3.5 Investment and Funding Landscape
4 Global Eubiotics Market (by Offering Type)
4.1 Market Overview
4.2 Probiotics
4.2.1 Lactobacilli
4.2.2 Bifidobacterium
4.2.3 Streptococcus Thermophilus
4.2.4 Other Probiotics
4.3 Prebiotics
4.3.1 Inulin
4.3.2 Fructo-Oligosaccharides
4.3.3 Galacto-Oligosaccharides
4.3.4 Mannan-Oligosaccharides
4.4 Organic Acids
4.4.1 Formic Acid
4.4.2 Lactic Acid
4.4.3 Fumaric Acid
4.4.4 Propionic Acid
4.4.5 Others
4.5 Essential oils
5 Global Eubiotics Market (by Application)
5.1 Market Overview
5.2 Gut Health
5.3 Immunity
5.4 Yield Management
5.5 Others
6 Global Eubiotics Market (by Livestock)
6.1 Market Overview
6.2 Swine
6.3 Poultry
6.4 Ruminants
6.5 Aquaculture
6.6 Other Livestock
7 Global Eubiotics Market (by Form)
7.1 Market Overview
7.2 Solid or Dry Form
7.3 Liquid Form
8 Global Eubiotics Market (by End User)
8.1 Market Overview
8.2 Humans
8.3 Animals
8.3.1 Industrial Livestock
8.3.2 Domesticated Animals
9 Global Eubiotics Market (by Packaging Type)
9.1 Market Overview
9.2 Stand-up Pouches/Portion Control
9.3 Bulk Packaging
9.3.1 Packet Packaging
9.3.2 Bucket Packaging
10 Global Eubiotics Market (by Region)
10.1 Market Overview
10.2 North America
10.3 South America
10.4 U.K.
10.5 China
10.6 Europe
10.7 Asia-Pacific & Japan
10.8 Middle East and Africa
11 Company Profiles
- ADDCON GmbH
- Anpario plc.
- Archer Daniels Midland
- BASF SE
- BEHN MEYER
- BENEO GmbH
- BioGaia AB
- Bluestar Adisseo Co
- Calpis Co., Ltd.
- Cargill, Inc.
- Chr. Hansen Holding A/S
- DuPont de Nemours, Inc.
- Kemin Industries, Inc.
- Koninklijke DSM N.V.
- LALLEMAND Inc.
- Lesaffre
- MSPrebiotics Inc.
- Neospark Drugs and Chemicals Private Limited
- Novozymes A/S
- Novus International, Inc.
- Roquette Freres
- Yara International ASA
For more information about this report visit https://www.researchandmarkets.com/r/w80xvs
